Clinical Trial Update: Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating decitabine with peripheral stem cell transplantation in patients relapsed after bone marrow transplantation for leukemia, my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: COMPLETED